Stelac Advisory Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,868
Closed -$122K 92
2019
Q1
$122K Hold
1,868
0.06% 100
2018
Q4
$122K Sell
1,868
-445
-19% -$33.2K 0.06% 91
2018
Q3
$182K Buy
+2,313
New +$165K 0.05% 84
2017
Q4
Sell
-11,708
Closed -$952K 72
2017
Q3
$952K Buy
11,708
+4,605
+65% +$364K 0.29% 29
2017
Q2
$572K Hold
7,103
0.19% 31
2017
Q1
$558K Hold
7,103
0.18% 33
2016
Q4
$560K Buy
+7,103
New +$575K 0.19% 37

Other funds holding CVS

Stelac Advisory Services's CVS Position: Q2 2019 in Review

Stelac Advisory Services sold out of CVS Health (CVS) in Q2 2019, closing a stake of 1,868 shares — an estimated $122K sold.

Stelac Advisory Services first reported a position in CVS in Q4 2016 and held it in 7 quarters. The position peaked at $952K in Q3 2017. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

  • Stelac Advisory Services reported no remaining CVS Health position as of Q2 2019 after selling out during the quarter.
  • Stelac Advisory Services sold 1,868 CVS Health shares in Q2 2019, an estimated $122K.
  • Stelac Advisory Services first reported a position in CVS Health in Q4 2016 and held it in 7 quarters.
  • Stelac Advisory Services's CVS Health position peaked at $952K in Q3 2017.
  • 1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Stelac Advisory Services's 13F filing for Q2 2019, filed 29 Jul 2019.